GlassScriptPhysician profile
Nina Cahan
NPI 1154405595
$1,822.06
in general payments reported to CMS, 2019-2025
20 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $297 · 2021: $232 · 2022: $168 · 2023: $535 · 2024: $292 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $483.55 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $321.14 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $176.78 | 2020-2024 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $126.13 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $106.90 | 2019-2025 | |
| Lilly USA, LLC | $95.75 | 2022-2024 | Mounjaro |
| Idorsia Pharmaceuticals US INC | $81.49 | 2022-2024 | Quviviq |
| Bausch Health US, LLC | $68.69 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.73 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $57.84 | 2021-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Amgen INC. | $46.13 | 2024-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $37.59 | 2023-2024 | Veozah |
| Therapeuticsmd, INC. | $33.53 | 2019-2020 | |
| Genentech USA, INC. | $21.83 | 2021 | |
| Tonix Medicines, INC. | $21.72 | 2025 | Tonmya |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linus Health, INC. | $20.30 | 2023 | |
| Vbi Vaccine (Delaware) INC. | $17.37 | 2022 | |
| Eisai INC. | $16.46 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.08 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Cahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.